オクヤマ　リョウ   OKUYAMA Ryo   奥山 亮    所属   立命館アジア太平洋大学  国際経営学部    職種   教授
言語種別	英語
発行・発表の年月	2024/03
形態種別	学術論文
査読	査読あり
標題	Trends in COVID-19 Vaccine Development: Vaccine Platform, Developer, and Nationality.
執筆形態	単著
掲載誌名	Vaccines
掲載区分	国外
巻・号・頁	12(3),pp.259
総ページ数	14
担当区分	筆頭著者,責任著者
著者・共著者	Ryo Okuyama
概要	Vaccine platforms and developers involved in COVID-19 vaccine development were analyzed, elucidating the trends of vaccine platforms used, the country distribution of the developers, and differences in the profiles of developers by vaccine platforms and country. Conventional, established, and emerging vaccine platforms have been widely used and that older platforms are more advanced in clinical development. It also demonstrated the emergence of China, in addition to the U.S., while many pharmerging countries have been engaged in development. Startups have significantly contributed to the development of viral vector and RNA-based vaccines, suggesting their important role in the application of novel technologies. The major developers differ by country and region. Alliances, including international collaborations, have progressed in late clinical development. Future perspectives of pandemic vaccine development and implications for policy and corporate strategies are discussed.
DOI	https://doi.org/10.3390/vaccines12030259